These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8339135)

  • 1. The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary?
    Doyle DV; Perrett D; Foster OJ; Ensor M; Scott DL
    Br J Rheumatol; 1993 Jul; 32(7):614-7. PubMed ID: 8339135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.
    Hill HF; Hill AG; Day AT; Brown RM; Golding JR; Lyle WH
    Ann Rheum Dis; 1979 Oct; 38(5):429-33. PubMed ID: 518142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy.
    Pullar T; Peaker S; Martin MF; Bird HA; Feely MP
    Br J Rheumatol; 1988 Oct; 27(5):381-4. PubMed ID: 3179627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
    Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
    Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.
    Takahashi K; Ogita T; Okudaira H; Yoshinoya S; Yoshizawa H; Miyamoto T
    Arthritis Rheum; 1986 Apr; 29(4):560-4. PubMed ID: 3707633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
    Börjesson O; Knutsson LP; Svensson B
    Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicentric ambulatory trial of Trolovol (D-penicillamine) in chronic polyarthritis].
    Tautz VI
    Z Rheumatol; 1975; 34(3-4):87-93. PubMed ID: 806188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The healing of the bone erosions during therapy with gold preparations and D-penicillamine in rheumatoid arthritis patients].
    Kanevskaia MZ; Krel' AA; Slobodina GA; Chichasova NV; Semenova OIu
    Ter Arkh; 1990; 62(5):36-8. PubMed ID: 2396215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
    Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response in relation to dose of penicillamine in the treatment of rheumatoid arthritis.
    Lyle WH
    Int J Clin Pharmacol Res; 1984; 4(6):403-8. PubMed ID: 6533084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-penicillamine treatment in rheumatoid arthritis monitored by plasma alfa-1-antitrypsin-IgA complexes and plasma and urinary sulphur containing aminoacids.
    Wollheim FA; Jeppsson JO; Laurell CB
    Scand J Rheumatol Suppl; 1979; (28):21-7. PubMed ID: 313074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.